|
FDA Grants Breakthrough Designation to Rapid Test for Xylazine, Veterinary Sedative Fueling Overdose Crisis
A Pennsylvania diagnostics company received a Breakthrough Device Designation from the U.S. Food and Drug Administration for its new rapid urine test to detect xylazine, a veterinary sedative increasingly mixed into illicit drugs that complicates overdose responses. The designation is expected to shorten the regulatory path for the test as health professionals seek better tools to identify shifting substance use patterns and address the growing overdose crisis. (Source: Medical Economics)
>>> Read More
Op-Ed: Boost Behavioral Health Funding Now Or Pay Much More Later
Advocates argue that New Jersey risks greater social and economic costs if the state does not increase investments in behavioral health care by tens of millions of dollars to stabilize provider rates and expand access to services that are currently strained by workforce shortages and unmet needs. They warn that without stronger funding commitments now, gaps in mental health and addiction treatment could deepen, leading to more crisis care and long-term impacts on communities and public systems. (Source: NJ Spotlight News)
>>> Read More
|